日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic landscape, immune microenvironment and survival in male versus female breast cancer

基因组图谱、免疫微环境与男性和女性乳腺癌患者的生存率

Trapani, D; Deshmukh, S K; Samec, T; Wu, S; Xiu, J; Walker, P; Abravanel, D L; Advani, P; Spanheimer, P M; Lin, N U; Curigliano, G; Graff, S L; Lustberg, M; Sledge, G W; Tolaney, S M; Leone, J P

Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors.

验证人工智能驱动的外显子组/转录组液体活检平台在实体瘤早期检测、微小残留病灶检测、疾病监测和治疗选择中的应用

Abraham J, Domenyuk V, Perdigones N, Klimov S, Antani S, Yoshino T, Heath E I, Lou E, Liu S V, Marshall J L, El-Deiry W S, Shields A F, Dietrich M F, Nakamura Y, Fujisawa T, Demetri G D, Barker A, Xiu J, Sacchetti D A, Stahl S, Hahn-Lowry R, Stark A, Swensen J, Poste G, Halbert D D, Oberley M, Radovich M, Sledge G W, Spetzler David B

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

第五版 ESO-ESMO 晚期乳腺癌国际共识指南(ABC 5)

Cardoso, F; Paluch-Shimon, S; Senkus, E; Curigliano, G; Aapro, M S; André, F; Barrios, C H; Bergh, J; Bhattacharyya, G S; Biganzoli, L; Boyle, F; Cardoso, M-J; Carey, L A; Cortés, J; El Saghir, N S; Elzayat, M; Eniu, A; Fallowfield, L; Francis, P A; Gelmon, K; Gligorov, J; Haidinger, R; Harbeck, N; Hu, X; Kaufman, B; Kaur, R; Kiely, B E; Kim, S-B; Lin, N U; Mertz, S A; Neciosup, S; Offersen, B V; Ohno, S; Pagani, O; Prat, A; Penault-Llorca, F; Rugo, H S; Sledge, G W; Thomssen, C; Vorobiof, D A; Wiseman, T; Xu, B; Norton, L; Costa, A; Winer, E P

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

第四版 ESO-ESMO 晚期乳腺癌国际共识指南 (ABC 4)†

Cardoso, F; Senkus, E; Costa, A; Papadopoulos, E; Aapro, M; André, F; Harbeck, N; Aguilar Lopez, B; Barrios, C H; Bergh, J; Biganzoli, L; Boers-Doets, C B; Cardoso, M J; Carey, L A; Cortés, J; Curigliano, G; Diéras, V; El Saghir, N S; Eniu, A; Fallowfield, L; Francis, P A; Gelmon, K; Johnston, S R D; Kaufman, B; Koppikar, S; Krop, I E; Mayer, M; Nakigudde, G; Offersen, B V; Ohno, S; Pagani, O; Paluch-Shimon, S; Penault-Llorca, F; Prat, A; Rugo, H S; Sledge, G W; Spence, D; Thomssen, C; Vorobiof, D A; Xu, B; Norton, L; Winer, E P

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

基因变异可预测ECOG-5103和ECOG-2100中贝伐珠单抗诱发的高血压

Schneider, B P; Li, L; Shen, F; Miller, K D; Radovich, M; O'Neill, A; Gray, R J; Lane, D; Flockhart, D A; Jiang, G; Wang, Z; Lai, D; Koller, D; Pratt, J H; Dang, C T; Northfelt, D; Perez, E A; Shenkier, T; Cobleigh, M; Smith, M L; Railey, E; Partridge, A; Gralow, J; Sparano, J; Davidson, N E; Foroud, T; Sledge, G W

A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group

一项II期试点试验,旨在评估贝伐单抗联合高剂量多柔比星和环磷酰胺方案,随后序贯紫杉醇治疗淋巴结阳性乳腺癌患者的疗效:该试验由东部肿瘤协作组协调开展。

Miller, K D; O'Neill, A; Perez, E A; Seidman, A D; Sledge, G W

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

乳腺癌向激素非依赖性生长进展过程中NF-κB的组成型激活

Nakshatri, H; Bhat-Nakshatri, P; Martin, D A; Goulet, R J Jr; Sledge, G W Jr